Need an investment idea? Check out S2O Stock Screener. It allows to generate a list of stocks of a particular interest in a matter of seconds!

Market Price

93.00 

2.16 2.4%

as of Sep 23 '21

52 Week Range:

61.75 99.80


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Blackmores Limited develops, sells, and markets natural health products for humans and animals in Australia, New Zealand, Asia, China, and internationally. The company offers vitamins, and herbal and mineral nutritional supplements. It also provides products for various conditions related to arthritis, joints, bones, and muscles; brain health; cold, flu, and immunity; digestive health; energy and exercise; essentials; everyday health; and eye health. In addition, the company offers products in the areas of fish and nutritional oils; heart and circulation; infant nutrition; kids health; men's health; multivitamins; nails, hair, and skin; pet health; probiotics; pregnancy and preconception; stress relief and sleep support; weight management; and women's health. It provides its products through retail and online channels. The company was founded in 1930 and is headquartered in Sydney, Australia.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Jun '12 Dec '12 Jun '13 Jun '14 Jun '15 Jun '16 Jun '17 Jun '18 Jun '19 Jun '20 Jun '21
Equity (BVPS) 4.77
4.30
5.31
5.73
6.75
9.24
9.96
10.44
12.07
11.57
19.15
growth rate -9.9% 23.5% 7.9% 17.8% 36.9% 7.8% 4.8% 15.6% -4.1% 65.5%
Earnings BIT 39.20
39.00
40.63
73.61
147.25
87.84
108.45
79.34
22.37
49.51
growth rate -0.3% 4.2% 81.2% 100.1% -40.4% 23.5% -26.8% -71.8% 121.3%
Avg.PE 15.82
18.21
19.64
40.58
47.94
17.02
40.51
21.64
65.52
92.49
growth rate 7.3% 7.9% 106.6% 18.1% -64.5% 138.0% -46.6% 202.8% 41.2%
ROA 16.96
12.30
10.87
17.57
27.50
13.95
15.96
11.19
3.44
5.10
growth rate -14.8% -11.6% 61.6% 56.5% -49.3% 14.4% -29.9% -69.3% 48.3%
ROE 33.62
27.10
25.14
39.26
64.28
33.17
37.80
26.72
7.07
8.44
growth rate -10.2% -7.2% 56.2% 63.7% -48.4% 14.0% -29.3% -73.5% 19.4%
ROIC 23.77
18.00
15.98
27.60
49.32
25.28
27.19
18.84
5.90
7.56
growth rate -13.0% -11.2% 72.7% 78.7% -48.7% 7.6% -30.7% -68.7% 28.1%
Cur. Ratio 2.41
2.75
2.26
1.63
1.53
1.81
1.73
2.03
2.28
2.23
growth rate 6.8% -17.8% -27.9% -6.1% 18.3% -4.4% 17.3% 12.3% -2.2%
Quick Ratio 1.58
1.81
1.54
1.25
0.90
1.17
1.07
1.12
1.08
1.24
growth rate 7.0% -14.9% -18.8% -28.0% 30.0% -8.6% 4.7% -3.6% 14.8%
Leverage 2.03
2.36
2.27
2.21
2.43
2.32
2.41
2.37
1.84
1.50
growth rate 7.8% -3.8% -2.6% 10.0% -4.5% 3.9% -1.7% -22.4% -18.5%
Balance Sheet Jun '12 Dec '12 Jun '13 Jun '14 Jun '15 Jun '16 Jun '17 Jun '18 Jun '19 Jun '20 Jun '21
Acct.Receivable 54.00
64.00
70.57
107.08
134.64
132.15
150.79
143.88
93.35
120.75
growth rate 8.9% 10.3% 51.7% 25.7% -1.9% 14.1% -4.6% -35.1% 29.3%
Acct.Payable 14.00
23.00
25.93
52.84
102.10
75.82
98.72
79.36
46.41
63.61
growth rate 28.2% 12.7% 103.8% 93.2% -25.7% 30.2% -19.6% -41.5% 37.1%
Cur.Assets 100.00
124.00
131.38
187.84
294.62
258.66
302.51
308.22
303.36
321.63
growth rate 11.4% 6.0% 43.0% 56.9% -12.2% 17.0% 1.9% -1.6% 6.0%
Total Assets 175.00
231.00
236.59
293.41
443.36
412.17
464.85
493.62
550.83
560.42
growth rate 14.9% 2.4% 24.0% 51.1% -7.0% 12.8% 6.2% 11.6% 1.7%
Cash 12.00
18.00
18.60
36.93
37.65
34.25
36.47
24.52
47.66
70.05
growth rate 22.5% 3.3% 98.6% 2.0% -9.0% 6.5% -32.8% 94.4% 47.0%
Inventory 32.00
40.00
38.74
38.67
116.49
84.79
103.97
125.10
120.72
115.69
growth rate 11.8% -3.2% -0.2% 201.3% -27.2% 22.6% 20.3% -3.5% -4.2%
Cur.Liabilities 42.00
45.00
58.04
115.00
192.28
142.56
174.47
153.21
130.50
144.17
growth rate 3.5% 29.0% 98.1% 67.2% -25.9% 22.4% -12.2% -14.8% 10.5%
Liabilities 89.00
133.00
132.37
160.49
262.77
233.36
271.52
285.91
249.99
181.47
growth rate 22.2% -0.5% 21.3% 63.7% -11.2% 16.4% 5.3% -12.6% -27.4%
LT Debt 46.00
87.00
73.25
44.00
55.45
78.97
86.00
119.00
85.00
growth rate 37.5% -15.8% -39.9% 26.0% 42.4% 8.9% 38.4% -28.6%
Equity 86.30
98.10
104.23
132.92
178.26
177.54
192.88
207.29
299.50
373.16
growth rate 6.6% 6.2% 27.5% 34.1% -0.4% 8.6% 7.5% 44.5% 24.6%
Common Shares 17.00
17.00
17.00
17.00
17.00
17.00
17.00
17.00
17.00
17.00
19.00
growth rate 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 11.8%
Cash Flow Statement Jun '12 Dec '12 Jun '13 Jun '14 Jun '15 Jun '16 Jun '17 Jun '18 Jun '19 Jun '20 Jun '21
Capital Expenditures 5.00
5.00
4.66
3.63
13.85
14.50
10.77
14.74
11.68
11.02
growth rate 0.0% -6.8% -22.2% 282.0% 4.7% -25.7% 36.8% -20.7% -5.7%
Cash Dividends 20.80
15.70
18.09
22.70
57.70
58.57
49.96
39.93
9.92
4.17
growth rate -13.1% 15.2% 25.5% 154.2% 1.5% -14.7% -20.1% -75.2% -57.9%
Cash From OA 21.00
22.00
37.49
71.13
83.68
45.63
58.03
19.83
55.84
58.45
growth rate 2.4% 70.4% 89.7% 17.6% -45.5% 27.2% -65.8% 181.6% 4.7%
FCF per Share 0.87
1.33
0.49
1.70
2.82
5.32
-0.69
3.64
2.62
0.72
3.10
growth rate 52.9% -63.2% 246.9% 65.9% 88.7% -100.0% 100.0% -28.0% -72.5% 330.6%
FCF 16.00
22.00
17.00
33.00
68.00
70.00
31.00
42.00
5.10
39.00
40.00
growth rate 37.5% -22.7% 94.1% 106.1% 2.9% -55.7% 35.5% -87.9% 665.2% 2.6%
Income Statement Jun '12 Dec '12 Jun '13 Jun '14 Jun '15 Jun '16 Jun '17 Jun '18 Jun '19 Jun '20 Jun '21
Sales 262.00
327.00
346.76
388.33
598.44
552.71
601.85
593.47
571.85
577.73
growth rate 11.7% 6.0% 12.0% 54.1% -7.6% 8.9% -1.4% -3.6% 1.0%
Op.Income 28.00
39.00
40.63
73.61
147.25
87.84
108.45
79.34
22.37
49.51
growth rate 18.0% 4.2% 81.2% 100.1% -40.4% 23.5% -26.8% -71.8% 121.3%
IBT 39.20
34.00
34.96
68.83
143.41
82.05
97.68
71.56
19.18
42.26
growth rate -6.9% 2.8% 96.9% 108.4% -42.8% 19.1% -26.7% -73.2% 120.4%
Net Income 28.00
25.00
25.43
46.56
100.01
59.01
70.01
53.47
15.11
28.62
growth rate -5.5% 1.7% 83.1% 114.8% -41.0% 18.6% -23.6% -71.7% 89.4%
EPS 1.65
1.46
1.48
1.49
2.69
5.76
3.40
4.06
3.09
1.04
1.48
growth rate -11.5% 1.4% 0.7% 80.5% 114.1% -41.0% 19.4% -23.9% -66.3% 42.3%
Gross Profit 179.00
218.00
231.39
237.31
379.49
308.77
360.59
346.77
329.76
355.48
growth rate 10.4% 6.1% 2.6% 59.9% -18.6% 16.8% -3.8% -4.9% 7.8%
R&D 6.70
7.90
1.17
1.17
1.17
2.04
growth rate 8.6% -61.5% 0.0% 0.0% 73.8%

Quarterly Statements

Item Name Jun '20 Sep '20 Dec '20 Mar '21 Jun '21
Earnings BIT 15.84
15.84
8.92
8.92
growth rate 0.0% -43.7% 0.0%
Balance Sheet Jun '20 Sep '20 Dec '20 Mar '21 Jun '21
Acct.Receivable 97.86
117.57
117.57
120.75
120.75
growth rate 20.1% 0.0% 2.7% 0.0%
Acct.Payable 46.41
114.52
114.52
63.61
63.61
growth rate 146.7% 0.0% -44.5% 0.0%
Cur.Assets 307.86
304.42
304.42
321.63
321.63
growth rate -1.1% 0.0% 5.7% 0.0%
Total Assets 561.13
546.17
546.17
560.42
560.42
growth rate -2.7% 0.0% 2.6% 0.0%
Cash 47.66
71.03
71.03
70.05
70.05
growth rate 49.1% 0.0% -1.4% 0.0%
Inventory 120.72
100.57
100.57
115.69
115.69
growth rate -16.7% 0.0% 15.0% 0.0%
Cur.Liabilities 135.01
138.81
138.81
144.17
144.17
growth rate 2.8% 0.0% 3.9% 0.0%
Liabilities 254.49
172.57
172.57
181.47
181.47
growth rate -32.2% 0.0% 5.2% 0.0%
LT Debt 85.00
growth rate
Equity 305.30
370.76
370.76
373.16
373.16
growth rate 21.4% 0.0% 0.7% 0.0%
Common Shares 146.39
194.59
194.59
196.13
196.13
growth rate 32.9% 0.0% 0.8% 0.0%
Cash Flow Statement Jun '20 Sep '20 Dec '20 Mar '21 Jun '21
Capital Expenditures 4.31
4.31
4.31
1.19
1.19
growth rate 0.0% 0.0% -72.3% 0.0%
Cash Dividends 2.09
2.09
2.09
2.09
growth rate 0.0% 0.0% 0.0%
Cash From OA 22.71
22.71
22.71
6.52
6.52
growth rate 0.0% 0.0% -71.3% 0.0%
FCF 18.39
18.39
18.39
5.32
5.32
growth rate 0.0% 0.0% -71.1% 0.0%
Income Statement Jun '20 Sep '20 Dec '20 Mar '21 Jun '21
Sales 151.51
151.51
137.36
137.36
growth rate 0.0% -9.3% 0.0%
Op.Income 15.84
15.84
15.84
8.92
8.92
growth rate 0.0% 0.0% -43.7% 0.0%
IBT 11.81
11.81
11.81
9.33
9.33
growth rate 0.0% 0.0% -21.0% 0.0%
Net Income 9.46
9.46
4.85
4.85
growth rate 0.0% -48.7% 0.0%
Gross Profit 91.94
91.94
85.80
85.80
growth rate 0.0% -6.7% 0.0%
R&D
growth rate

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

D (40.04)

YOY Growth Grade:

D (44.57)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 87.51 91.36 16.62
EPS / Growth 7.1% 1.02 11.0%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 21.1%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 7.1% 13.1% 13.1%
Future PE 14.12 21.38 21.38
Future EPS 2.01 3.48 3.48
Value Price
MOS %
7.03
-92.4%
18.38
-80.2%
18.38
-80.2%
MOS Price 3.51 9.19 9.19
IRT 28.57 19.92 19.92

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.